BVF PARTNERS L P/IL
CIK 1055947
Transactions on file
31
Open-market buys
3
Win rate (buys)
100%
3 scored
Avg % since filing (buys)
+74.8%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | 2026-05-14 | XOMA XOMA Royalty Corp | 10% | C | 772,000 | $3.11M | +940.9% | open → |
| 2026-05-18 | 2026-05-14 | XOMA XOMA Royalty Corp | 10% | C | 412,000 | $1.66M | +940.9% | open → |
| 2026-05-18 | 2026-05-14 | XOMA XOMA Royalty Corp | 10% | C | 1,506,000 | $6.07M | +940.9% | open → |
| 2026-05-18 | 2026-05-14 | XOMA XOMA Royalty Corp | 10% | C | 2,313,000 | $9.32M | +940.9% | open → |
| 2025-01-14 | 2025-01-10 | OLMA Olema Pharmaceuticals, Inc. | DirectorOther | Disp. | 22,740 | — | — | open → |
| 2025-01-14 | 2025-01-10 | OLMA Olema Pharmaceuticals, Inc. | DirectorOther | Disp. | 235,450 | — | — | open → |
| 2025-01-14 | 2025-01-10 | OLMA Olema Pharmaceuticals, Inc. | DirectorOther | Disp. | 161,810 | — | — | open → |
| 2025-01-28 | 2025-01-24 | XOMA XOMA Royalty Corp | 10% | Sale | 339,679 | $8.87M | +60.7% | open → |
| 2025-01-28 | 2025-01-24 | XOMA XOMA Royalty Corp | 10% | Sale | 149,975 | $3.91M | +60.7% | open → |
| 2025-01-28 | 2025-01-24 | XOMA XOMA Royalty Corp | 10% | Sale | 85,776 | $2.24M | +60.7% | open → |
| 2025-01-28 | 2025-01-24 | XOMA XOMA Royalty Corp | 10% | Sale | 75,287 | $1.96M | +60.7% | open → |
| 2025-05-19 | 2025-05-15 | ALLK Allakos Inc. | 10% | Disp. | 6,777,935 | — | — | open → |
| 2025-05-19 | 2025-05-15 | ALLK Allakos Inc. | 10% | Disp. | 8,679,726 | — | — | open → |
| 2025-05-19 | 2025-05-15 | ALLK Allakos Inc. | 10% | Disp. | 855,211 | — | — | open → |
| 2025-05-20 | 2025-05-16 | XOMA XOMA Royalty Corp | 10% | Sale | 265,316 | $7.19M | +54.8% | open → |
| 2025-05-20 | 2025-05-16 | XOMA XOMA Royalty Corp | 10% | Sale | 127,407 | $3.45M | +54.8% | open → |
| 2025-06-17 | 2025-06-13 | CBIO GLYCOMIMETICS INC | 10% | Other | 657,308 | — | — | open → |
| 2025-06-17 | 2025-06-13 | CBIO GLYCOMIMETICS INC | 10% | Other | 556,617 | — | — | open → |
| 2025-06-17 | 2025-06-13 | CBIO GLYCOMIMETICS INC | 10% | Other | 56,079 | — | — | open → |
| 2025-10-14 | 2025-10-09 | EPIX ESSA Pharma Inc. | 10% | U | 560,797 | $0.00 | — | open → |
| 2025-10-14 | 2025-10-09 | EPIX ESSA Pharma Inc. | 10% | U | 4,726,743 | $0.00 | — | open → |
| 2025-10-14 | 2025-10-09 | EPIX ESSA Pharma Inc. | 10% | U | 6,194,145 | $0.00 | — | open → |
| 2025-07-01 | 2025-06-30 | KYMR Kymera Therapeutics, Inc. | DirectorOther | Buy | 142,604 | $6.27M | +74.8% | open → |
| 2025-07-01 | 2025-06-30 | KYMR Kymera Therapeutics, Inc. | DirectorOther | Buy | 115,783 | $5.09M | +74.8% | open → |
| 2025-07-01 | 2025-06-30 | KYMR Kymera Therapeutics, Inc. | DirectorOther | Buy | 58,780 | $2.59M | +74.8% | open → |
| 2025-08-07 | 2025-08-05 | EPIX ESSA Pharma Inc. | 10% | X | 203,336 | $0.00 | — | open → |
| 2025-08-07 | 2025-08-05 | EPIX ESSA Pharma Inc. | 10% | X | 1,235,030 | $0.00 | — | open → |
| 2025-08-07 | 2025-08-05 | EPIX ESSA Pharma Inc. | 10% | X | 1,481,634 | $0.00 | — | open → |
| 2025-08-07 | 2025-08-05 | EPIX ESSA Pharma Inc. | 10% | Sale | 66 | $124.08 | — | open → |
| 2025-08-07 | 2025-08-05 | EPIX ESSA Pharma Inc. | 10% | Sale | 11 | $20.68 | — | open → |
| 2025-08-07 | 2025-08-05 | EPIX ESSA Pharma Inc. | 10% | Sale | 79 | $148.52 | — | open → |
